Emerging FLT3 inhibitors for the treatment of acute myeloid leukemia-Reference-Cited by-同舟云学术

Emerging FLT3 inhibitors for the treatment of acute myeloid leukemia

Published:2022-01-02 Issue:1 Volume:27 Page:1-18
ISSN:1472-8214
Container-title:Expert Opinion on Emerging Drugs
language:en
Short-container-title:Expert Opinion on Emerging Drugs

Author:

Solana-Altabella Antonio¹²^ORCID,Ballesta-López Octavio¹²^ORCID,Megías-Vericat Juan Eduardo¹^ORCID,Martínez-Cuadrón David¹²^ORCID,Montesinos Pau²³^ORCID

Affiliation:

1. Servicio de Farmacia, Área del Medicamento. Hospital Universitari i Politècnic La Fe. Av. Fernando Abril Martorell, Valencia– Spain

2. Instituto de Investigación Sanitaria La Fe (IISLAFE). Av. Fernando Abril Martorell, Valencia–Spain

3. Servicio de Hematología y Hemoterapia. Hospital Universitari i Politècnic La Fe. Av. Fernando Abril Martorell, Valencia-Spain

Funder

Instituto de Investigación Sanitaria La Fe

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14728214.2021.2009800

Reference93 articles.

1. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

2. Optimizing survival outcomes with post‐remission therapy in acute myeloid leukemia

3. Recent drug approvals for acute myeloid leukemia

4. Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia

5. Interim Analysis of the Phase 1b/2 Study of the BCL-2 Inhibitor Venetoclax in Combination with Standard Intensive AML Induction/Consolidation Therapy with FLAG-IDA in Patients with Newly Diagnosed or Relapsed/Refractory AML

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Principal-Agent Theoretical Ramifications on Digital Transformation of Ports in Emerging Economies;Logistics;2024-05-08

2. Cancer-Stem-Cell Phenotype-Guided Discovery of a Microbiota-Inspired Synthetic Compound Targeting NPM1 for Leukemia;JACS Au;2024-02-09

3. AML under the Scope: Current Strategies and Treatment Involving FLT3 Inhibitors and Venetoclax-Based Regimens;International Journal of Molecular Sciences;2023-10-31

4. Classification of FLT3 inhibitors and SAR analysis by machine learning methods;Molecular Diversity;2023-05-05

5. Clinical Uses of Inhaled Antifungals for Invasive Pulmonary Fungal Disease: Promises and Challenges;Journal of Fungi;2023-04-12